Tag: Cogent Biosciences
Cogent Biosciences ($COGT) Begins $150 Million Share Sale
Cogent Biosciences (COGT) has launched an underwritten public offering of $150 million in common stock. The company plans to use the net proceeds to...
Cogent Biosciences ($COGT) stock jumps 17% pre-market on positive SUMMIT trial data
Cogent Biosciences, Inc. (NASDAQ: COGT) surged 17.28% following positive top-line results from SUMMIT clinical trial in pre-market trading on Monday, July 7, 2025, reaching...
Cogent Biosciences ($COGT) Achieves Significant Improvement in Mastocytosis Study
Cogent Biosciences, Inc. (COGT) announced positive top-line results from the registration-directed Part 2 of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced...